"The company has completed GMP manufacturing of its Ii-Key-SARS-CoV-2 peptides and plans to submit its FDA IND to initiate clinical trials as soon as possible." I guess this line means it hasn't been submitted yet.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
